文献速递乳腺癌

肿瘤浸润淋巴细胞与预后:早期三阴性乳腺癌的汇总个体患者分析

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
PubMed 文献 · J Clin Oncol · 2019-01-16

该汇总分析纳入9项研究、2148例接受蒽环类联合或不联合紫杉类辅助化疗的早期三阴性乳腺癌患者,评估间质肿瘤浸润淋巴细胞(sTILs)的预后价值。sTILs每增加10%,侵袭无病生存(iDFS)、远处无病生存(D-DFS)和总生存(OS)风险均降低,提示sTILs具有独立预后作用,支持将其纳入临床病理预后模型。

要点

  • sTILs每增加10%,iDFS的HR为0.87(95%CI 0.83-0.91),D-DFS的HR为0.83(95%CI 0.79-0.88),OS的HR为0.84(95%CI 0.79-0.89)。
  • 淋巴结阴性且sTILs≥30%的患者,3年iDFS为92%(95%CI 89%-98%),D-DFS为97%(95%CI 95%-99%),OS为99%(95%CI 97%-100%)。
  • sTILs与年龄较大、肿瘤较大、淋巴结受累较多及组织学分级较低显著相关(P值分别为0.001、0.01、0.02、0.001)。

核心结论

  • 该汇总数据分析证实sTILs在早期三阴性乳腺癌中具有强预后作用,高sTILs患者接受辅助化疗后生存极佳,支持将sTILs整合入三阴性乳腺癌的临床病理预后模型,该模型可见于www.tilsinbreastcancer.org。

研究设计与样本

  • 参与研究均在早期三阴性乳腺癌患者诊断样本中以相同方式量化间质肿瘤浸润淋巴细胞(sTILs)的浸润百分比,患者接受蒽环类联合或不联合紫杉类化疗。
  • 采用按试验分层的Cox比例风险回归模型,将sTILs作为连续变量并校正临床病理因素,分析iDFS(主要终点)、D-DFS和OS。
  • 共收集来自9项研究的2148例患者的个体数据。

主要发现

  • 患者平均年龄50岁(范围22至85岁),33%为淋巴结阴性;sTILs平均值为23%(标准差20%),77%的患者sTILs≥1%。
  • sTILs在年龄较大(P=0.001)、肿瘤较大(P=0.01)、淋巴结受累较多(P=0.02)和组织学分级较低(P=0.001)的患者中显著更低。
  • 共观察到736例iDFS事件、548例D-DFS事件和533例死亡。
  • 多变量模型中,sTILs为所有终点增加显著独立预后信息(似然比χ2:iDFS 48.9,P<0.001;D-DFS 55.8,P<0.001;OS 48.5,P<0.001)。
  • sTILs每增加10%,iDFS的HR为0.87(95%CI 0.83-0.91),D-DFS的HR为0.83(95%CI 0.79-0.88),OS的HR为0.84(95%CI 0.79-0.89)。

关键数值与推荐

  • 淋巴结阴性且sTILs≥30%的患者,3年iDFS为92%(95%CI 89%-98%),3年D-DFS为97%(95%CI 95%-99%),3年OS为99%(95%CI 97%-100%)。

临床怎么用

  • 作者认为sTILs在早期三阴性乳腺癌中具有强预后作用,并支持将sTILs整合入三阴性乳腺癌的临床病理预后模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the current study was to conduct a pooled analysis of studies that have investigated the prognostic value of tumor-infiltrating lymphocytes (TILs) in early-stage triple negative breast cancer (TNBC). METHODS: Participating studies had evaluated the percentage infiltration of stromally located TILs (sTILs) that were quantified in the same manner in patient diagnostic samples of early-stage TNBC treated with anthracycline-based chemotherapy with or without taxanes. Cox proportional hazards regression models stratified by trial were used for invasive disease-free survival (iDFS; primary end point), distant disease-free survival (D-DFS), and overall survival (OS), fitting sTILs as a continuous variable adjusted for clinicopathologic factors. RESULTS: We collected individual data from 2,148 patients from nine studies. Average age was 50 years (range, 22 to 85 years), and 33% of patients were node negative. The average value of sTILs was 23% (standard deviation, 20%), and 77% of patients had 1% or more sTILs. sTILs were significantly lower with older age ( P = .001), larger tumor size ( P = .01), more nodal involvement ( P = .02), and lower histologic grade ( P = .001). A total of 736 iDFS and 548 D-DFS events and 533 deaths were observed. In the multivariable model, sTILs added significant independent prognostic information for all end points (likelihood ratio χ2, 48.9 iDFS; P < .001; χ2, 55.8 D-DFS; P < .001; χ2, 48.5 OS; P < .001). Each 10% increment in sTILs corresponded to an iDFS hazard ratio of 0.87 (95% CI, 0.83 to 0.91) for iDFS, 0.83 (95% CI, 0.79 to 0.88) for D-DFS, and 0.84 (95% CI, 0.79 to 0.89) for OS. In node-negative patients with sTILs ≥ 30%, 3-year iDFS was 92% (95% CI, 89% to 98%), D-DFS was 97% (95% CI, 95% to 99%), and OS was 99% (95% CI, 97% to 100%). CONCLUSION: This pooled data analysis confirms the strong prognostic role of sTILs in early-stage TNBC and excellent survival of patients with high sTILs after adjuvant chemotherapy and supports the integration of sTILs in a clinicopathologic prognostic model for patients with TNBC. This model can be found at www.tilsinbreastcancer.org .

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Loi S, Drubay D, Adams S, et al. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. J Clin Oncol. 2019. PMID: 30650045. doi:10.1200/JCO.18.01010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。